Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 6/20 | 0.53 |
| ▸ | CA2 | P00918 | 6/20 | 0.53 |
| ▸ | CES2 | O00748 | 2/20 | 0.50 |
| ▸ | CES1 | P23141 | 2/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.50 |
| ▸ | PLK1 | P53350 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | PARP1 | P09874 | 1/20 | 0.47 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.47 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.47 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL417437 | 0.84 | TSHR (0.50) | CES2CES1CYP19A1MAPTSMN1; SMN2 | |
| SCHEMBL6652179 | 0.83 | CA1 (0.56) | CA1CA2CES2CES1CYP19A1 | |
| SCHEMBL6652176 | 0.83 | CA1 (0.56) | CA1CA2CES2CES1CYP19A1 | |
| SCHEMBL10617986 | 0.82 | CA1 (0.59) | CA1CA2CES2CES1PLK1 | |
| SCHEMBL6049096 | 0.82 | CA1 (0.59) | CA1CA2CES2CES1PLK1 | |
| SCHEMBL6653882 | 0.80 | CA1 (0.63) | CA1CA2CES2CES1CYP19A1 | |
| SCHEMBL6653891 | 0.80 | CA1 (0.63) | CA1CA2CES2CES1CYP19A1 | |
| SCHEMBL6653888 | 0.80 | CA1 (0.63) | CA1CA2CES2CES1CYP19A1 | |
| SCHEMBL5325112 | 0.78 | CA1 (0.59) | CA1CA2CES2CES1PLK1 | |
| SCHEMBL17736157 | 0.77 | CA1 (0.50) | CA1CA2CES2CES1PLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230303608-A1 | DITHIOLENE METAL COMPLEXES | BASF SCHWEIZ AG (CH) | 2023-09-28 | — | — | US | disclosed |
| US-20230295439-A1 | NAPHTHALOCYANINE AND PHTHALOCYANINE PARTICLES | BASF SE (DE) | 2023-09-21 | — | — | US | disclosed |
| EP-3697835-A1 | FLAME-RETARDANT AND COLOR-STABLE POLYAMIDE MOLDING COMPOUNDS | Clariant Plastics & Coatings Ltd (CH) | 2020-08-26 | — | — | EP | disclosed |
| WO-2019076688-A1 | FLAME-RETARDANT AND COLOR-STABLE POLYAMIDE MOLDING COMPOUNDS | CLARIANT PLASTICS & COATINGS LTD (CH) | 2019-04-25 | — | — | WO | disclosed |
| US-9232785-B2 | Method for reducing sunburn damage in plants | BASF SE (DE) | 2016-01-12 | — | — | US | disclosed |
| US-8748347-B2 | Method for combating harmful fungi | BASF SE (DE) | 2014-06-10 | — | — | US | disclosed |
| US-20120083497-A1 | Method for Combating Harmful Fungi | BASF SE (DE) | 2012-04-05 | — | — | US | disclosed |
| EP-2418944-A2 | METHOD FOR COMBATING HARMFUL FUNGI | BASF SE (DE) | 2012-02-22 | — | — | EP | disclosed |
| EP-2413691-A2 | METHOD FOR REDUCING SUNBURN DAMAGE IN PLANTS | BASF SE (DE) | 2012-02-08 | — | — | EP | disclosed |
| US-20120017503-A1 | METHOD FOR REDUCING SUNBURN DAMAGE IN PLANTS | BASF SE (DE) | 2012-01-26 | — | — | US | disclosed |
| EP-1743928-A1 | SEALING MATERIAL COMPOSITION | KANEKA CORPORATION (JP) | 2007-01-17 | — | — | EP | disclosed |
| EP-1689799-A1 | STABILIZATION OF POLYETHER POLYOLS, POLYESTER POLYOLS AND POLYURETHANES | Ciba SC Holding AG (CH) | 2006-08-16 | — | — | EP | disclosed |
| WO-2005054328-A1 | STABILIZATION OF POLYETHER POLYOLS, POLYESTER POLYOLS AND POLYURETHANES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-06-16 | — | — | WO | disclosed |
| EP-1392779-A1 | FLUORINATED-PHOTOINITIATORS IN DUAL CURE RESINS | Ciba SC Holding AG (CH) | 2004-03-03 | — | — | EP | disclosed |
| US-20030035917-A1 | Image making medium | HYMAN SYDNEY (US) | 2003-02-20 | — | — | US | disclosed |
| WO-2002040602-A1 | FLUORINATED-PHOTOINITIATORS IN DUAL CURE RESINS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-05-23 | — | — | WO | disclosed |
| US-4798822-A | PHOTOSTABILIZERS FOR POLYMERS | CIBA-GEIGY CORPORATION (US) | 1989-01-17 | — | — | US | disclosed |
| US-4661594-A | PHOTODEGRADATION INHIBITION | CIBA-GEIGY CORPORATION (US) | 1987-04-28 | — | — | US | disclosed |
| US-4525504-A | 1,4-CYCLOHEXANDEICARBOXYLIC ACID AND 2,2,4,4-TETRAMETHYL-1,3-CYCLOBUTANEDIOL, UV AND HINDERED AMINE STABILIZERS | EASTMAN KODAK COMPANY (US) | 1985-06-25 | — | — | US | disclosed |
| US-4524165-A | 1,4-CYCLOHEXANEDICARBOXYLIC ACID AND 1,4-CYCLOHEXANE DIOL MONOMERS; POLYALKYLENE GLCOLS; STABILIZER MIXTURE | EASTMAN KODAK COMPANY (US) | 1985-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303608-A1 | DITHIOLENE METAL COMPLEXES | TST, C1S, F12 | CA1 3705/4885CA2 3981/4885CES2 4719/4885 |
| US-20230295439-A1 | NAPHTHALOCYANINE AND PHTHALOCYANINE PARTICLES | IK, NRP1, LCP1 | CA1 3405/4885CA2 3418/4885CES2 3593/4885 |
| US-20120017503-A1 | METHOD FOR REDUCING SUNBURN DAMAGE IN PLANTS | UNG, ERCC5, ERCC4 | CA1 4299/4885CA2 1862/4885CES2 1204/4885 |
| US-20120083497-A1 | Method for Combating Harmful Fungi | BROX, CRY1, GUSB | CA1 1580/4885CA2 1156/4885CES2 3118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.